News
Analysts estimate that Merck & Co will report an earnings per share (EPS) of $2.01. Investors in Merck & Co are eagerly ...
The JAK-inhibitor will be available to veterinarians and itchy dog owners in the United Kingdom by the end of Q3 2025.
Animal health company Zoetis has partnered with the Beyond Blue mental health charity since 2016, donating more than $900,000 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results